glp-1 agonist constipation Why Matters While on GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated side effect of and GIP-1 agonists like semaglutide (Wegovy®) or tirzepatide (Zepbound®). Left untreated, it can lead Constipation is a common side

Pharmacotherapy can help people with obesity achieve and maintain their target weight loss, thereby reducing the risk of obesity-related complications

Development of unimolecular agents targeting both GIPR and GLP-1R The anti-obesity effects of GIPR antagonism antibody, both alone and in combination with GLP-1RAs, have been demonstrated in preclinical models of mice and monkeys (68, 73)

This article will review the role of GLP-1 in lipid metabolism in detail

19-22 Warnings and precautions: Several post-marketing reports of serious adverse events associated with DPP-4 inhibitors have led to the addition of several warnings and precautions to the U.S

Mitochondrial dysfunction has negative effects on the body and is believed to be an important factor in aging and disease

[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Campbell JE, et al